Cart

0

Stocks

“Morgan Stanley Predicts up to 110% Rally for These 2 ‘Strong Buy’ Stocks”

Auna S.A. (AUNA)

Cepeda’s views back up his Overweight (Buy) rating on the stock, and his $14 price-target points toward a robust 110% upside potential for the next 12 months. (To watch Cepeda’s track record, click here)…

Contineum Therapeutics (CTNM)

Hung goes on to put an Overweight (Buy) rating on this stock, and he complements that with a $25 price target, suggesting the shares have a 69% upside potential on the one-year horizon. (To watch Hung’s track record, click here)…”

https://finance.yahoo.com/news/morgan-stanley-predicts-110-rally-124425359.html

My opinion on these stocks are extremely bias but I’ll say this anyway. Anyone who has read my website for a while knows I mostly invest in penny stocks. I have NEVER seen pharmaceutical stocks increase over time. They always reverse stock split and decrease long term. I know that info’s bias because I only deal with penny stocks, but man I’d be hard pressed to buy any of these stocks long term. Short term on the other hand could be amazing.

Leave a Reply